Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG - World Stem Cell Summit

Stem cell therapy TED-A9 showing safety and early efficacy in trial

by admin | Dec 16, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Margarida Maia, PhD – Parkinson’s News Today – The first six Parkinson’s disease patients given the investigational stem cell-based therapy TED-A9 in a clinical trial showed safety and an easing in their symptoms over one year of follow-up, the...

High Response Rate for CAR T-Cell Therapy in Patients With Fast-Growing Leukemia

by admin | Dec 13, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Technology Networks – A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia. Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel...

A Mayo Clinic collaboration studies engineered stem cells for liver disease

by admin | Dec 12, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Susan Buckles – Mayo Clinic – Mayo Clinic’s Center for Regenerative Biotherapeutics is collaborating with the biotech firm HepaTx on an experimental therapy to regenerate tissue in patients with late-stage liver disease. This new technology takes...

Local News How a landmark UC Davis Health clinical trial to treat spina bifida gave one Roseville family hope

by admin | Dec 11, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Dina Kupfer – CBS News – SACRAMENTO — A landmark clinical trial is underway at UC Davis Health: the world’s first spina bifida treatment combining fetal surgery with stem cells. A child taking their first steps marks a major milestone, but for...

Silk-based biomaterials for promoting spinal cord regeneration: A review

by admin | Dec 10, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Science Direct – The management of neurological disorders is profoundly complicated by spinal cord injury (SCI), which leads to the impairment of motor and sensory functions. A major challenge in the treatment of SCI is the formation of a dysfunctional...

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

by admin | Dec 9, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By VHIO – One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast cancer with a poorer prognosis. Investigators of the VHIO’s Growth Factors Group, and the Cancer Research Program of Hospital del...